Craneの空売り状況は、投資家がCraneの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Crane (NYSE:CR) 株価情報, 空売り情報

Crane

Crane Holdings

Crane is a diversified industrial firm that manufactures a broad range of products, including valves, pumps, aerospace components, and fiberglass-reinforced plastic panels. Its business is organized into two segments: aerospace and electronics, and process flow technologies. Crane generated approximately $2.1 billion in revenue in 2024.

Crane Co

Crabada

C-Rad AB

CRA International Inc

VanEck Oil Refiners ETF

Credit Agricole SA

CREDIT AGRICOLE UNSP/ADR by Credit Agricole SA

CRAWFORD UNITED CORP by Crawford United Corporation

Crawford United Corp

CRAYON GROUP HLDG AS by Crayon Group HLDG AS

Crayon Group Holding ASA

Carbeeza Inc

CORBY SPIRIT AND WINE B by Corby Spirit and Wine Ltd.

Corby Spirit and Wine Ltd

Corebridge Financial Inc. 6.375% Junior Subordinated Notes due 2064

Corebridge Financial Inc

CHINA RESOURCES LAND LTD by China Resources Land Ltd.

China Resources Land Ltd

CHINA RES LAND UNSP/ADR by China Resources Land Ltd.

CAREBOOK TECHNOLOGIES INC by CAREBOOK TECHNOLOGIES INC.

iShares MSCI ACWI Low Carbon Target ETF

CARBON ENERGY CORP by Carbon Energy Corporation

Carbon Energy Corp

Corbus Pharmaceuticals Holdings, Inc. - Common Stock

Corbus Pharmaceuticals Holdings Inc

CARBON TRANSITION ASA by CARBON TRANSITION ASA

Caribou Biosciences Inc

California Resources Corporation Common Stock

California Resources Corp

CHONGQUING RURAL COML BK by Chongquing Rural Commercial Bank Co Ltd.

Chongqing Rural Commercial Bank Co Ltd

CRRC Corp Ltd

Circle Energy Inc

California Resources Corp Warrants(27/10/2024)

Cricut Inc

Canagold Resources Ltd

The Crypto Co

Crawford & Co

CRD Network

Cardinal Ethanol LLC

Cardiff Oncology Inc

CONCORDIA FINCL UNSP/ADR by Concordia Financial Group, Ltd.

Concordia Financial Group Ltd

Cardiol Therapeutics Inc. - Class A Common Shares

Cardiol Therapeutics Inc

Credo Technology Group Holding Ltd - Ordinary Shares

Credo Technology Group Holding Ltd

Cerrado Gold Inc

Simplify Exchange Traded Funds Simplify Opportunistic Income ETF

COMMUNITY REDEVELOPMENT by COMMUNITY REDEVELOPMENT INC.

Community Redevelopment Inc

Carry

CREATIVE TECH LTD ORD by Creative Technology Ltd.

Creative Technology Ltd

Cream Finance

CREATIVE TECH LTD UNS/ADR by Creative Technology Ltd.

CRITICAL ELEMENTS LITHIUM by Critical Elements Lithium Corporation

Critical Elements Lithium Corp

Columbia ETF Trust I Columbia Research Enhanced Real Estate ETF

Crescera Capital Acquisition Corp lass A

Smart Powerr Corp

CRE Logistics REIT Inc

COREO AG by Coreo AG

CHINA RARE EARTH HLDGS by China Rare Earth Holdings Ltd.

China Rare Earth Holdings Ltd

Carrefour

Cresud SACIF y A

Cresud S.A.C.I.F. y A. - American Depositary Shares, each representing ten shares of Common Stock

Crescera Capital Acquisition Corp Units (1 Ord Share Class A & 1/2 War)

Carbon Revolution Public Limited Company - Ordinary Shares

Carbon Revolution PLC

Carbon Revolution Ltd Ordinary Shares

Carbon Revolution Public Limited Company - Warrant

Creative Realities Inc

Creative Realities Inc Warrants (09/11/2022)

Cornerstone Total Return Fund, Inc. (The) Common Stock

Cornerstone Total Return Fund Inc

Card Factory PLC

Zedcor Inc

BC CRAFT SUPPLY CO NEW by BC CRAFT SUPPLY CO LTD.

BC Craft Supply Co Ltd

CAREFREE GROUP INC by Carefree Group, Inc.

Carefree Group Inc

Charge Enterprises Inc

CHINA RES GAS GRP ORD by China Resources Gas Group Ltd

China Resources Gas Group Ltd

CARRIAGE HOUSE EVENT CTR by Carriage House Event Center Inc.

Carriage House Event Center Inc

Freightos Ltd

CALISSIO RES GROUP INC by Calissio Resources Group, Inc.

Calissio Resources Group Inc

Cargo Therapeutics Inc

Crescent Energy Company Class A Common Stock

Crescent Energy Co

CRH PLC

CROSS HARBOUR HLDGS LTD by Cross-Harbour Holdings Ltd.

Cross-Harbour (Holdings) Ltd

CHINA RES BEER HLDGS by China Resources Beer Holdings Company Limited

China Resources Beer (Holdings) Co Ltd

CHINA RES BEER HLDG S/ADR by China Resources Beer Holdings Company Limited

Carter's Inc

Churchill Resources Inc

Curis Inc

Exchange Traded Concepts Trust Optica Rare Earths & Critical Materials ETF

CHINA RUNJI CEMENT INC by China Runji Cement, Inc.

China Runji Cement Inc

Comstock Resources Inc

Crank Media Inc

CROWN ELECTROKINETICS CRP by Crown Electrokinetics Corp.

Crown ElectroKinetics Corp

Creek Road Miners Inc

Prairie Operating Co

CIRMAKER TECHNOLOGY CORP by Cirmaker Technology Corp.

Cirmaker Technology Corp

Charles River Laboratories International, Inc. Common Stock

Charles River Laboratories International Inc

Cresco Labs Inc

CARDINAL ENERGY LTD ORD by Cardinal Energy Ltd.

Cardinal Energy Ltd

CIRCUIT RESEARCH LABS INC by Circuit Research Labs, Inc.

Circuit Research Labs Inc

CENTRAL PRKNG F/T 5.25PFD by Central Parking Finance Trust

Central Parking Financial Trust

Cerillion PLC

Salesforce Inc

CRUMBS BAKE SHOP INC by Crumbs Bake Shop, Inc.

Crumbs Bake Shop Inc

Cormedix Inc

Carmila SA

CERMETEK MICROELECTRONICS by Cermetek Microelectronics, Inc.

Cermetek Microelectronics Inc

Ratings for Crane (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CR#NYSE">CR</a>) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $175.75, with a high estimate of $200.00 and a low estimate of $157.00. This upward trend is evident, with the current average reflecting a 2.03% increase from the previous average price target of $172.25.
<img src="https://www.benzinga.com/files/images/story/2025/1738274456_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Crane. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Matt Summerville</td>
<td>DA Davidson</td>
<td>Raises</td>
<td>Buy</td>
<td>$200.00</td>
<td>$185.00</td>
</tr>
<tr>
<td>Nathan Jones</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Hold</td>
<td>$170.00</td>
<td>$176.00</td>
</tr>
<tr>
<td>Damian Karas</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$157.00</td>
<td>$152.00</td>
</tr>
<tr>
<td>Nathan Jones</td>
<td>Stifel</td>
<td>Maintains</td>
<td>Hold</td>
<td>$176.00</td>
<td>$176.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Crane. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Crane compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Crane's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Crane's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CR/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Crane analyst ratings.</a>
<h2>Delving into Crane's Background</h2>
Crane is a diversified industrial firm that manufactures a broad range of products, including valves, pumps, aerospace components, and fiberglass-reinforced plastic panels. Its business is organized into two segments: aerospace and electronics, and process flow technologies. Crane generated approximately $2.1 billion in revenue in 2024.
<h3>Unraveling the Financial Story of Crane</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Decline in Revenue: Over the 3 months period, Crane faced challenges, resulting in a decline of approximately -8.89% in revenue growth as of 31 December, 2024. This signifies a reduction in the company's top-line earnings. When compared to others in the Industrials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Crane's net margin excels beyond industry benchmarks, reaching 14.89%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Crane's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 5.04%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Crane's ROA excels beyond industry benchmarks, reaching 3.07%. This signifies efficient management of assets and strong financial health.
Debt Management: Crane's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.15.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

Where Crane Stands With Analysts

DA Davidson analyst Matt Summerville maintains Crane (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CR#NYSE">CR</a>) with a Buy and raises the price target from $185 to $200.

News

Price Target

DA Davidson Maintains Buy on Crane, Raises Price Target to $200

U.S. stocks traded higher toward the end of trading, with the Dow Jones index rising over 150 points on Tuesday.
The Dow traded up 0.34% to 44,865.65 while the NASDAQ rose 1.74% to 19,678.66. The S&amp;P 500 also rose, gaining, 0.83% to 6,062.21.
Check This Out: <a href="https://www.benzinga.com/news/earnings/25/01/43266326/how-to-earn-500-a-month-from-starbucks-stock-ahead-of-q1-earnings">How To Earn $500 A Month From Starbucks Stock Ahead Of Q1 Earnings</a>
Leading and Lagging Sectors Information technology shares surged by 2.9% on Tuesday.
In trading on Tuesday, utilities shares fell by 1.9%.
Top Headline
Shares of Boeing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) gained around 4% on Tuesday after the company reported fourth-quarter results.
The company reported a 31% year-over-year revenue decline to $15.242 billion in the fourth quarter of 2024, missing the consensus of $16.174 billion.
Adjusted loss per share grew to $5.90 from $0.47 in the same quarter of 2023, missing the consensus of a $2.44 loss.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Brighthouse Financial, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BHF#NASDAQ">BHF</a>) shares shot up 17% to $59.68 following a report the company is trying to sell itself.</li>
<li>Shares of Silexion Therapeutics Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLXN#NASDAQ">SLXN</a>)got a boost, surging 100% to $1.16 after the company reported new preclinical data for SIL-204 showing significant tumor reduction in pancreatic cancer models.</li>
<li>Crane Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CR#NYSE">CR</a>) shares were also up, gaining 12% to $175.93 following fourth-quarter results.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Sharps Technology, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STSS#NASDAQ">STSS</a>) shares dropped 71% to $0.4300 after the company announced a $20 million underwritten public offering.</li>
<li>Shares of Leap Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LPTX#NASDAQ">LPTX</a>) were down 70% to $0.6639 after the company reported initial clinical data from Part B of the DeFianCe study and Part C of the DisTinGuish study.</li>
<li>SAB Biotherapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SABS#NASDAQ">SABS</a>) was down, falling 49% to $2.22 after the company disclosed topline Phase 1 clinical results for SAB-142, showing drug was generally well tolerated among healthy volunteers.</li>
</ul>
Commodities In commodity news, oil traded up 0.3% to $73.37 while gold traded up 1.1% at $2,768.40.
Silver traded up 1.4% to $30.845 on Tuesday, while copper rose 0.6% to $4.2570.
Euro zone
European shares were mostly higher today. The eurozone's STOXX 600 rose 0.36%, Germany's DAX 40 gained 0.70% and France's CAC 40 fell 0.12%. Spain's IBEX 35 Index rose 1.31%, while London's FTSE 100 rose 0.35%.
Asia Pacific Markets
Asian markets closed mixed on Tuesday, with Japan's Nikkei 225 falling 1.39%, Hong Kong's Hang Seng Index gaining 0.14% and India's BSE Sensex gaining 0.71%.
Economics
<ul>
<li>U.S. durable goods orders declined 2.2% month-over-month to $276.1 billion in December, following a revised 2% decline in November.</li>
<li>The S&amp;P CoreLogic Case-Shiller 20-city home price index rose 4.3% year-over-year in November, compared to 4.2% in the previous month.</li>
<li>The FHFA house price index rose 0.3% in November, topping market estimates of a 0.2% increase.</li>
<li>The Dallas Fed general business activity index for Texas's service sector fell to 7.4 in January compared to a revised reading of 10.8 in December.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43266082/jim-cramer-coterra-energy-is-the-cheapest-natural-gas-company-recommends-buying-this-financial-stock">Jim Cramer Recommends Buying &#8216;Fabulous&#8217; BlackRock, Calls Coterra Energy The &#8216;Cheapest&#8217; Natural Gas Company</a></li>
</ul>

Earnings

Equities

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

Brighthouse Financial, Inc. - Common Stock

LPTX

SABS

SLXN

STSS

Gold Gains 1%; Boeing Shares Rise Following Q4 Results

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 300 points on Tuesday.
The Dow traded up 0.28% to 44,836.81 while the NASDAQ rose 1.69% to 19,669.65. The S&amp;P 500 also rose, gaining, 0.76% to 6,058.05.
Check This Out: <a href="https://www.benzinga.com/news/earnings/25/01/43266326/how-to-earn-500-a-month-from-starbucks-stock-ahead-of-q1-earnings">How To Earn $500 A Month From Starbucks Stock Ahead Of Q1 Earnings</a>
Leading and Lagging Sectors Communication services shares surged by 0.7% on Tuesday.
In trading on Tuesday, consumer discretionary shares fell by 0.7%.
Top Headline
Lockheed Martin Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) shares fell around 9% on Tuesday after the company reported mixed fourth-quarter 2024 results.
The company reported a net sales decline of 1.3% year-over-year to $18.622 billion, missing the consensus of $18.91 billion. LMT reported Adjusted EPS of $7.67, beating the consensus of $6.64.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Brighthouse Financial, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BHF#NASDAQ">BHF</a>) shares shot up 21% to $61.75 following a report the company is trying to sell itself.</li>
<li>Shares of Silexion Therapeutics Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLXN#NASDAQ">SLXN</a>)got a boost, surging 139% to $1.3909 after the company reported new preclinical data for SIL-204 showing significant tumor reduction in pancreatic cancer models.</li>
<li>Crane Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CR#NYSE">CR</a>) shares were also up, gaining 10% to $172.00 following fourth-quarter results.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Sharps Technology, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STSS#NASDAQ">STSS</a>) shares dropped 69% to $0.4542 after the company announced a $20 million underwritten public offering.</li>
<li>Shares of Leap Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LPTX#NASDAQ">LPTX</a>) were down 69% to $0.6969 after the company reported initial clinical data from Part B of the DeFianCe study and Part C of the DisTinGuish study.</li>
<li>SAB Biotherapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SABS#NASDAQ">SABS</a>) was down, falling 48% to $2.2496 after the company disclosed topline Phase 1 clinical results for SAB-142, showing drug was generally well tolerated among healthy volunteers.</li>
</ul>
Commodities In commodity news, oil traded up 0.3% to $73.38 while gold traded up 0.8% at $2,759.00.
Silver traded up 0.6% to $30.59 on Tuesday, while copper rose 0.6% to $4.2585.
Euro zone
European shares were higher today. The eurozone's STOXX 600 rose 0.54%, Germany's DAX 40 gained 0.51% and France's CAC 40 rose 0.18%. Spain's IBEX 35 Index rose 1.39%, while London's FTSE 100 rose 0.66%.
Asia Pacific Markets
Asian markets closed mixed on Tuesday, with Japan's Nikkei 225 falling 1.39%, Hong Kong's Hang Seng Index gaining 0.14% and India's BSE Sensex gaining 0.71%.
Economics
<ul>
<li>U.S. durable goods orders declined 2.2% month-over-month to $276.1 billion in December, following a revised 2% decline in November.</li>
<li>The S&amp;P CoreLogic Case-Shiller 20-city home price index rose 4.3% year-over-year in November, compared to 4.2% in the previous month.</li>
<li>The FHFA house price index rose 0.3% in November, topping market estimates of a 0.2% increase.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43266082/jim-cramer-coterra-energy-is-the-cheapest-natural-gas-company-recommends-buying-this-financial-stock">Jim Cramer Recommends Buying &#8216;Fabulous&#8217; BlackRock, Calls Coterra Energy The &#8216;Cheapest&#8217; Natural Gas Company</a></li>
</ul>

Nasdaq Surges More Than 300 Points; Lockheed Martin Shares Dip After Q4 Results

U.S. stocks were mixed, with the Dow Jones index falling around 0.1% on Tuesday.
Shares of Royal Caribbean Cruises Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCL#NYSE">RCL</a>) gained 6.2% to $251.48 following a fourth-quarter EPS beat.
Adjusted EBITDA for the quarter was $1.09 billion, with a margin of 29.2%. Adjusted EPS of $1.63 beat the consensus estimate of $1.50. The cruise operator reported fourth-quarter sales growth of 12.9% year-on-year to $3.761 billion, marginally missing the analyst consensus estimate of $3.765 billion.
Royal Caribbean Cruises shares climbed 6.2% to $251.48 on Tuesday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Brighthouse Financial, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BHF#NASDAQ">BHF</a>) shares gained 20.3% to $61.46 following a report the company is trying to sell itself.</li>
<li>BlackSky Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKSY#NASDAQ">BKSY</a>) rose 18.8% to $15.64. Blacksky Technology was awarded a more than $100 million contract from a long-term strategic partner in the international defense sector for real-time, space-based monitoring capabilities.</li>
<li>Surgery Partners, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGRY#NASDAQ">SGRY</a>) shares surged 17.2% to $24.90.</li>
<li>Radiopharm Theranostics Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RADX#NASDAQ">RADX</a>) gained 12.1% to 5.48. Radiopharm Theranostics recently announced it will execute a private placement and will raise $5 million in proceeds.</li>
<li>Exodus Movement, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EXOD#NYSE">EXOD</a>) climbed 8.8% to $80.54.</li>
<li>Crane Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CR#NYSE">CR</a>) shares gained 7.6% to $168.34 following fourth-quarter results.</li>
<li>Akero Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKRO#NASDAQ">AKRO</a>) rose 7.5% to $55.61. Akero Therapeutics announced a proposed public offering of common stock. Canaccord Genuity analyst Edward Nash maintained Akero Therapeutics with a Buy and raised the price target from $56 to $73, while Citigroup analyst Jonathan Woo maintained the stock with a Buy and raised the price target from $65 to $80.</li>
<li>Atlas Energy Solutions Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AESI#NYSE">AESI</a>) gained 7% to $26.42. RBC Capital analyst Keith Mackey maintained Atlas Energy Solutions with an Outperform and raised the price target from $27 to $28.</li>
<li>Invesco Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IVZ#NYSE">IVZ</a>) rose 7% to $18.99 following strong quarterly results.</li>
<li>Victoria&#8217;s Secret &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSCO#NYSE">VSCO</a>) gained 5% to $39.19. Barclays analyst Adrienne Yih upgraded Victoria&#8217;s Secret from Equal-Weight to Overweight and raised the price target from $51 to $53.</li>
<li>The Boeing Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) rose 4.2% to $182.44 following fourth-quarter results.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/01/43266326/how-to-earn-500-a-month-from-starbucks-stock-ahead-of-q1-earnings">How To Earn $500 A Month From Starbucks Stock Ahead Of Q1 Earnings</a></li>
</ul>

Movers

AESI

AKRO

BlackSky Technology Inc. Class A Common Stock

BKSY

EXOD

RADX

SGRY

VSCO

Royal Caribbean Cruises Posts Upbeat Earnings, Joins Brighthouse Financial, Invesco, Boeing And Other Big Stocks Moving Higher On Tuesday

WIIM

Crane shares are trading higher after the company reported a year-over-year increase in Q4 financial results, issued FY25 adjusted EPS guidance above estimates, and increased its quarterly dividend.

The Q4 earnings report for Crane (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CR#NYSE">CR</a>) was released on Monday, January 27, 2025 at 04:15 PM.
Here's what investors need to know about the latest announcement.
<h3>Earnings</h3>
Crane beat estimated earnings by 4.0%, reporting an EPS of $1.26 versus an estimate of $1.21.
Revenue was up $11.20 million from the same period last year.
<h3>Past Earnings Performance</h3>
The company beat on EPS by $0.06 in the last quarter, resulting in a 4.0% increase share price change the following day.
Here's a look at Crane's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.32</td>
<td>1.23</td>
<td>1.12</td>
<td>0.82</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.38</td>
<td>1.30</td>
<td>1.22</td>
<td>0.90</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>594.11M</td>
<td>562.67M</td>
<td>546.38M</td>
<td>520.59M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>597.20M</td>
<td>581.20M</td>
<td>565.30M</td>
<td>532.90M</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
Crane management provided guidance for FY 2025, expecting earnings between $5.3 and $5.6 per share.
To track all earnings releases for Crane <a href="https://www.benzinga.com/quote/CR/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Crane: Q4 Earnings Insights

Crane (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CR#NYSE">CR</a>) announced its Q4 earnings on Monday, January 27, 2025 at 04:15 PM.
Here's a breakdown of the earnings report.
<h3>Earnings</h3>
Crane beat estimated earnings by 4.0%, reporting an EPS of $1.26 versus an estimate of $1.21.
Revenue was up $11.20 million from the same period last year.
<h3>Overview of Past Earnings</h3>
In the previous quarter, the company beat on EPS by $0.06, resulting in a 4.0% increase change in the share price the following day.
Here's a look at Crane's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.32</td>
<td>1.23</td>
<td>1.12</td>
<td>0.82</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.38</td>
<td>1.30</td>
<td>1.22</td>
<td>0.90</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>594.11M</td>
<td>562.67M</td>
<td>546.38M</td>
<td>520.59M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>597.20M</td>
<td>581.20M</td>
<td>565.30M</td>
<td>532.90M</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
Crane management provided guidance for FY 2025, expecting earnings between $5.3 and $5.6 per share.
To track all earnings releases for Crane <a href="https://www.benzinga.com/quote/CR/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Crane Earnings Report: Q4 Overview

The Q4 earnings report for Crane (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CR#NYSE">CR</a>) was released on Monday, January 27, 2025 at 04:15 PM.
Here's what investors need to know about the latest announcement.
<h3>Earnings</h3>
Crane beat estimated earnings by 4.0%, reporting an EPS of $1.26 versus an estimate of $1.21.
Revenue was up $11.20 million from the same period last year.
<h3>Performance in Previous Earnings</h3>
The company beat on EPS by $0.06 in the last quarter, resulting in a 4.0% increase share price change the following day.
Here's a look at Crane's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.32</td>
<td>1.23</td>
<td>1.12</td>
<td>0.82</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.38</td>
<td>1.30</td>
<td>1.22</td>
<td>0.90</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>594.11M</td>
<td>562.67M</td>
<td>546.38M</td>
<td>520.59M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>597.20M</td>
<td>581.20M</td>
<td>565.30M</td>
<td>532.90M</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
Crane management provided guidance for FY 2025, expecting earnings between $5.3 and $5.6 per share.
To track all earnings releases for Crane <a href="https://www.benzinga.com/quote/CR/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Crane Earnings Analysis: Q4 Recap

Dividends

Crane Increases Quarterly Dividend From $0.205 To $0.23

The Q4 earnings report for Crane (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CR#NYSE">CR</a>) was released on Monday, January 27, 2025 at 04:15 PM.
Here's what investors need to know about the latest announcement.
<h3>Earnings</h3>
Crane beat estimated earnings by 4.0%, reporting an EPS of $1.26 versus an estimate of $1.21.
Revenue was up $11.20 million from the same period last year.
<h3>Historical Earnings Summary</h3>
The company beat on EPS by $0.06 in the previous quarter, leading to a 4.0% increase share price change the next day.
Here's a look at Crane's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.32</td>
<td>1.23</td>
<td>1.12</td>
<td>0.82</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.38</td>
<td>1.30</td>
<td>1.22</td>
<td>0.90</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>594.11M</td>
<td>562.67M</td>
<td>546.38M</td>
<td>520.59M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>597.20M</td>
<td>581.20M</td>
<td>565.30M</td>
<td>532.90M</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
Crane management provided guidance for FY 2025, expecting earnings between $5.3 and $5.6 per share.
To track all earnings releases for Crane <a href="https://www.benzinga.com/quote/CR/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insights into Crane Q4 Earnings

Guidance

Crane Sees FY25 Adj. EPS $5.30-$5.60 Vs $4.39 Est.

Crane Q4 Adj. EPS $1.26 Up From $0.80 YoY; Revenue $544M Up From $484M YoY

<h3>Companies Reporting Before The Bell</h3>
• MainStreet Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNSB#NASDAQ">MNSB</a>) is estimated to report quarterly earnings at $0.23 per share on revenue of $16.99 million. 
• Oxford Lane Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OXLC#NASDAQ">OXLC</a>) is estimated to report earnings for its third quarter. 
• SoFi Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>) is estimated to report quarterly earnings at $0.04 per share on revenue of $678.53 million. 
• Ryanair Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RYAAY#NASDAQ">RYAAY</a>) is likely to report quarterly earnings at $0.09 per share on revenue of $3.08 billion. 
• Dynex Cap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DX#NYSE">DX</a>) is projected to report quarterly earnings at $0.06 per share on revenue of $11.39 million. 
• Hope Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOPE#NASDAQ">HOPE</a>) is expected to report quarterly earnings at $0.19 per share on revenue of $119.97 million. 
• Bank of Hawaii (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOH#NYSE">BOH</a>) is expected to report quarterly earnings at $0.84 per share on revenue of $163.36 million. 
• Bank of Marin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMRC#NASDAQ">BMRC</a>) is expected to report quarterly earnings at $0.32 per share on revenue of $28.17 million. 
• AT&amp;T (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/T#NYSE">T</a>) is expected to report quarterly earnings at $0.51 per share on revenue of $31.95 billion. 
<h3>Companies Reporting After The Bell</h3>
• WSFS Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WSFS#NASDAQ">WSFS</a>) is expected to report quarterly earnings at $0.99 per share on revenue of $264.39 million. 
• WR Berkley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRB#NYSE">WRB</a>) is likely to report quarterly earnings at $0.95 per share on revenue of $2.98 billion. 
• Equity Lifestyle Props (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELS#NYSE">ELS</a>) is projected to report quarterly earnings at $0.76 per share on revenue of $375.04 million. 
• Transcat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRNS#NASDAQ">TRNS</a>) is expected to report quarterly earnings at $0.50 per share on revenue of $70.30 million. 
• Western Alliance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAL#NYSE">WAL</a>) is expected to report quarterly earnings at $1.91 per share on revenue of $804.88 million. 
• Five Star (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSBC#NASDAQ">FSBC</a>) is projected to report quarterly earnings at $0.57 per share on revenue of $34.09 million. 
• Sanmina (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SANM#NASDAQ">SANM</a>) is estimated to report quarterly earnings at $1.36 per share on revenue of $1.98 billion. 
• Nucor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUE#NYSE">NUE</a>) is expected to report quarterly earnings at $0.63 per share on revenue of $6.77 billion. 
• AGNC Investment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGNC#NASDAQ">AGNC</a>) is projected to report quarterly earnings at $0.43 per share on revenue of $209.06 million. 
• HomeStreet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HMST#NASDAQ">HMST</a>) is projected to report quarterly loss at $0.19 per share on revenue of $41.10 million. 
• Home Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HBCP#NASDAQ">HBCP</a>) is estimated to report quarterly earnings at $1.11 per share on revenue of $30.30 million. 
• Preferred Bank (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFBC#NASDAQ">PFBC</a>) is likely to report quarterly earnings at $2.39 per share on revenue of $69.74 million. 
• NBT Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NBTB#NASDAQ">NBTB</a>) is projected to report quarterly earnings at $0.77 per share on revenue of $147.11 million. 
• Marten Transport (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRTN#NASDAQ">MRTN</a>) is estimated to report quarterly earnings at $0.06 per share on revenue of $233.68 million. 
• PotlatchDeltic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCH#NASDAQ">PCH</a>) is expected to report quarterly loss at $0.02 per share on revenue of $246.71 million. 
• Graco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GGG#NYSE">GGG</a>) is estimated to report quarterly earnings at $0.77 per share on revenue of $553.25 million. 
• Crane (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CR#NYSE">CR</a>) is expected to report quarterly earnings at $1.27 per share on revenue of $583.71 million. 
• Brown &amp; Brown (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRO#NYSE">BRO</a>) is likely to report quarterly earnings at $0.77 per share on revenue of $1.12 billion. 
• Enterprise Finl Servs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EFSC#NASDAQ">EFSC</a>) is likely to report quarterly earnings at $1.20 per share on revenue of $162.20 million. 
• Servisfirst Bancshares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SFBS#NYSE">SFBS</a>) is likely to report quarterly earnings at $1.11 per share on revenue of $126.64 million. 
• Seacoast Banking (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBCF#NASDAQ">SBCF</a>) is projected to report earnings for its fourth quarter. 
• Alexandria Real Estate (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARE#NYSE">ARE</a>) is projected to report quarterly earnings at $2.39 per share on revenue of $788.78 million. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comments

Crane

空売り

Crane (NYSE:CR) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル